New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Drugs commonly prescribed for weight loss and diabetes may offer unexpected benefits in tackling substance abuse, according ...

Drugs originally designed to treat diabetes and obesity are reshaping medicine in unforeseen ways. Their impact on public health is really unprecedented in modern times, perhaps only upstaged by ...

A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.

A study of more than 600,000 veterans found that GLP-1 drugs — originally designed for diabetes and weight loss — cut ...

A study of more than 600,000 veterans found GLP-1 medications used for weight loss and diabetes may lower the risk of ...

In veterans with type 2 diabetes, treatment with GLP-1 receptor agonists was associated with a reduced risk for various substance use disorders compared with sodium-glucose cotransporter-2, or SGLT-2, ...

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

A large new study suggests they may drastically reduce the risk substance use disorders and drug-related deaths.

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

GLP-1 drugs may help reduce the risk of addiction to alcohol, cannabis, cocaine, nicotine, and opioids, a large US study has reported.

Gov. Mikie Sherrill said she will build on the harm reduction programs established by her predecessor, strategies that ...